News & Updates
Filter by Specialty:
Focal therapy an effective option for older, comorbid prostate cancer patients
Focal ablative therapy may be used as an alternative treatment for older or comorbid patients with prostate cancer who are not fit or willing to undergo radical treatment, suggests a study.
Focal therapy an effective option for older, comorbid prostate cancer patients
02 Jul 2023
Erdafitinib prevails in bladder cancer with select FGFRalt
The oral selective pan-FGFR tyrosine kinase inhibitor (TKI) erdafitinib demonstrated a survival advantage over chemotherapy, extending multiple efficacy endpoints in individuals with advanced or metastatic urothelial carcinoma (mUC) with FGFR alterations (FGFRalt) after previous anti-PD-(L)1 treatment, findings from the confirmatory phase III THOR trial have shown.
Erdafitinib prevails in bladder cancer with select FGFRalt
22 Jun 2023
Does extended lymph node sampling increase complications?
Patients undergoing more extensive lymph node sampling during surgery for a suspected malignant paediatric renal tumour do not appear to have a higher likelihood of experiencing clinically significant complications, reveals a study.
Does extended lymph node sampling increase complications?
06 Jun 2023
50-percent decrease in severity a meaningful endpoint in chronic pelvic pain
A clinically meaningful endpoint for future therapeutic trials in urological chronic pelvic pain syndrome is a decrease of 30‒50 percent in pelvic pain severity, suggests a study. Clinically significant differences for urinary symptom severity are more appropriately defined separately for males and females.
